00871nas a2200361   4500000000100000008004100001260000900042653002200051653001200073653001800085653001200103653003100115653001100146653001100157653001200168653000900180653000900189653002500198653001500223653002700238653001300265653001700278100001500295700001400310700001600324700001600340700001700356700002700373245007700400300001100477490000700488022001400495       1972                            d  c197210aAniline Compounds10aAnimals10aAntimalarials10aDapsone10aDrug Resistance, Microbial10aHumans10aImines10aleprosy10aMale10aMice10aMycobacterium leprae10aPhenazines10aPigmentation Disorders10aRifampin10aSulfonamides1 aPattyn S R1 aRollier R1 aRollier M R1 aDe Muynck A1 aJANSSENS P G1 aVerdoolaeghe-Van Loo G00aCorrelation of laboratory and clinical data during treatment of leprosy.  a537-480 v52  a0772-4128